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Abstract
Background—Cardiovascular disease (CVD) screening in Title X settings can identify low-
income women at risk of future chronic disease. This study examines follow-up related to newly 
identified CVD risk factors in a Title X setting.
Methods—Female patients at a North Carolina Title X clinic were screened for CVD risk factors 
(n = 462) and 167/462 (36.1%) were rescreened one year later. Clinical staff made protocol-driven 
referrals for women identified with newly diagnosed CVD risk factors. We used paired t-tests and 
chi square tests to compare screening and rescreening results (two-tailed, p < 0.05).
Results—Among 11 women in need of referrals for newly diagnosed hypertension or diabetes, 9 
out of 11 (81.8%) were referred, and 2 of 11 (18.2%) completed referrals. Among hypertensive 
women who were rescreened (n = 21), systolic blood pressure decreased (139 to 132 mmHg, p = 
0.001) and diastolic blood pressure decreased (90 to 83 mmHg, p = 0.006). Hemoglobin A1c did 
not improve among rescreened diabetic women (n = 5, p = 0.640). Among women who reported 
smoking at enrollment, 129 of 148 (87.2%) received cessation counseling and 8 of 148 (5.4%) 
accepted tobacco quitline referrals. Among smokers, 53 out of 148 (35.8%) were rescreened and 
11 of 53 (20.8%) reported nonsmoking at that time. Among 188 women identified as obese at 
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enrollment, 22 (11.7%) scheduled nutrition appointments, but only one attended. Mean weight 
increased from 221 to 225 pounds (p < 0.05) among 70 out of 188 (37.2%) obese women who 
were rescreened.
Conclusions—The majority of women in need of referrals for CVD risk factors received them. 
Few women completed referrals. Future research should examine barriers and facilitators of 
referral care among low-income women.
Introduction
Low-income women of reproductive age have greater rates of cardiovascular disease (CVD) 
risk factors compared with their higher income counterparts.1 A study published by the 
current authors demonstrated that many low-income women accessing reproductive health 
services at a North Carolina health department Title X family planning clinic had CVD 
precursors (pre-hypertension, borderline high cholesterol, or prediabetes) or risk factors 
(smoking or obesity).2 Optimizing low-income women’s health during reproductive years 
may impact their long-term health and may also prevent adverse pregnancy outcomes such 
as low birth weight, preterm deliveries, and birth defects.3
Title X is a federal program that provides subsidized contraceptive services for more than 
five million low-income patients annually, and health departments are major providers of 
Title X services.4 Most women who receive family planning services through Title X report 
that their family planning provider is also their usual source of health care.2,5 Because Title 
X clinics routinely screen for CVD risk factors, such as hypertension, smoking and obesity, 
these clinics frequently identify CVD risk factors among low-income women.
Title X clinics are expected to refer women for conditions identified during family planning 
visits that require medical care, but for which the clinics may lack resources to treat, such as 
hypertension. While making referrals are a requirement of Title X funding, only a few 
studies have examined referral patterns in family planning clinic settings.6,7 One study 
found that providers in those settings were more likely to refer women testing positive for 
human immunodeficiency virus when providers were aware of local available referral 
resources.6 Another study reported family planning patients were more likely to seek follow-
up care for abnormal Papanicolaou (Pap) tests if they were told by their provider where to 
obtain the follow-up care.7
To our knowledge, no published studies have documented referral practices related to 
management of CVD risk factors identified in Title X settings. This study examines the 
outcomes of referrals for CVD risk factors (hypertension, diabetes, smoking, and obesity) 
among nonpregnant women receiving family planning services at a Title X clinic in North 
Carolina, and examines whether CVD risk factors improved one year later among women 
who screened positive.
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The research design and methods of the Integrated Screening and Health Assessment, 
Prevention and Evaluation (InShape) Study have been described elsewhere.2 Participants 
were enrolled and offered screening for CVD risk factors at an initial or annual family 
planning visit at a Title X family planning clinic in Pitt County, North Carolina. A research 
assistant obtained written informed consent from participants that included permission to 
request medical records related to referrals. Upon enrollment, participants were also 
informed that they would have the opportunity to be rescreened for CVD risk factors when 
they returned for their next annual family planning visit. At the screening visit, clinical staff 
made referrals and offered follow-up care for women with screening values requiring 
medical management according to clinic protocols. At the subsequent annual family 
planning visit, participants were rescreened for CVD risk factors and completed a self-
administered questionnaire that included questions about health practices and health history.
Sample
Women eligible for the screening study were nonpregnant, English speaking, ages 18–44 
years, and attending the Pitt County family planning clinic for an initial or annual 
reproductive health exam between May 23, 2011, and February 28, 2012. Among eligible 
women, 54% (462/859) enrolled and participated in the screening. Eligibility criteria for 
InShape rescreening at the subsequent annual visit were participation in the initial screening 
and being nonpregnant when they returned for their subsequent annual visit, which occurred 
at least 12 months after the screening visit. If a participant did not return within 13 months 
for the annual visit, research staff called and mailed letters to remind her about the 
opportunity to be rescreened. The Institutional Review Board of the University of North 
Carolina, Chapel Hill approved and monitored this study.
Measurement
We describe outcomes of referrals among the women who were newly identified with 
hypertension or diabetes at enrollment and report results from the InShape rescreening, 
which involved the same screening measures that were previously reported.2 In accordance 
with the health department protocol for usual clinical care, blood pressure (BP) was assessed 
with a single nurse-administered measurement using automated equipment. Blood samples 
were obtained for hemoglobin A1c assessment and sent to a commercial laboratory 
(LabCorp). Tobacco use and demographic characteristics were obtained from the self-
administered questionnaire. Obesity (body mass index [BMI] ≥ 30kg/m2) was determined by 
clinical measurement of weight (kilograms) and height (meters).
Criteria for referrals
According to the health department’s existing protocol, which was adapted from the Seventh 
Report of the Joint National Committee on Prevention, Detection, Evaluation, and 
Treatment of High Blood Pressure,8 the threshold for hypertension referral was systolic or 
diastolic BP ≥ 160/95 mmHg.
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The newly developed clinic protocol for elevated blood glucose recommended that all 
women with A1c levels ≥ 6.5% be referred to the health department’s diabetes self-
management program for further evaluation. Women with screening A1c values 6.5%–7.5% 
had to have a repeat A1c three months later that was ≥ 6.5% before an external referral was 
indicated. All women with screening A1c values > 7.5% met criteria for external referrals.
An existing clinic protocol required that the clinic nurse provide five A’s counseling (Ask, 
Advise, Assess, Assist, Arrange) on smoking cessation9 and information about the tobacco 
quitline to patients who smoke. Patients who smoke were also offered help from a trained 
smoking cessation counselor and if accepted, a referral form was faxed to the tobacco 
quitline.
An existing clinic protocol for obesity screening and referral was revised to add referral 
options available through the InShape program. All obese patients were invited to participate 
in either the InShape lifestyle intervention for nutritional education and promotion of 
physical activity or the weight loss program. Obese patients with BMI ≥ 40 kg/m2 or a BMI 
≥ 35 kg/m2 plus comorbidities (i.e., hypertension, diabetes, elevated lipids) also had the 
option of a referral to medical nutrition therapy services provided by the Pitt County Health 
Department.
Referral process
Family planning clinic staff received training on the newly developed protocol for A1c 
screening. When family planning clinic staff identified participants who met referral criteria, 
designated health department staff arranged formal referrals by phone and informed 
participants of their referral appointments. The health department provided information on 
formal referrals to research staff, including indication for referral, date referral was made, 
and the medical practice receiving the referral (i.e., referral resource). Clinicians also made 
informal referrals, which we define as verbal referrals that were documented in the medical 
record (i.e., “patient told to follow-up with…”), but not arranged by the health department 
staff. Research staff (TK, CR, SF) reviewed the medical charts of all participants with 
indicated referrals to verify formal and informal referrals. For both formal and informal 
referrals, research staff requested medical records from referral resources for the 12-month 
time period after the date of the screening visit.
Analytic plan
To compare participants who received rescreening with those who did not, we examined 
differences in distributions of demographic characteristics and CVD risk factors from the 
enrollment visit using Fisher’s exact tests. We calculated percent of women who received 
referrals and the percent of women who completed referrals. To examine changes in CVD 
risk factors over time, we compared the mean values of BP and A1c from enrollment and the 
subsequent annual visit among women with abnormal levels, respectively. We report the 
mean differences and 95% confidence intervals (CIs) for those values. Similarly, we 
compared mean values of weight from enrollment and the subsequent annual visit among 
obese women and we assessed change in smoking status among smokers who were 
rescreened using chi square tests. For sensitivity analyses, we repeated comparison analyses 
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of those same measures using the full sample of women who returned for the subsequent 
annual visit. All reported significance tests and 95% CIs are two-tailed (p < 0.05). Analyses 
were conducted with Stata v.13 (StataCorp LP, 2013).
Results
Among the 462 women who were screened at enrollment, a total of 167 (36.2%) were 
rescreened at their subsequent annual visit between 12 and 22 months (median = 13) after 
study enrollment. Loss rates include 48 (10.4%) women who became pregnant and were 
ineligible for screening at the subsequent annual visit, 13 (2.8%) who declined participation, 
32 (6.9%) who visited the family planning clinic 12–22 months after screening, but were 
missed by research staff and were not offered rescreening, and 202 (43.7%) who did not 
return for an annual visit within the study period. No statistically significant differences on 
baseline demographics or CVD risk factors were found between 167 women who were 
rescreened and 295 who were not (Table 1).
Of CVD risk factors identified at enrollment that met referral criteria [hypertension, n = 13 
(2.8%); diabetes, n = 7 (1.5%)], 11 out of 20 (73.3%) were new diagnoses (Fig. 1). Of the 11 
women with new diagnoses, formal referrals were made for 6 women (54.5%), informal 
referrals were made for 3 (27.3%), and 2 (18.2%) women were not referred. For the 11 
newly diagnosed women, 6 referrals (54.5%) were made to the local federally qualified 
community health center (CHC), 2 (18.2%) were made to the local university medical 
center, and 1 (9.1%) was made to a clinic in a neighboring community. Among 11 women 
who met referral criteria, 2 (18.2%) completed referrals: one was the result of a formal 
referral to the university medical center and the other resulted from an informal referral to 
the neighboring community clinic.
Twenty-one women identified with hypertension at screening were rescreened. The 
maximum systolic BP detected was 160 mmHg and the maximum diastolic BP detected was 
114 mmHg. The overall mean systolic BP decreased 7 mmHg (139 mmHg to 132 mmHg, p 
= 0.001) and diastolic BP decreased 7 mmHg (90 mmHg to 83 mmHg, p = 0.006) at 
rescreening among these women (Table 2). In sensitivity analyses that included all women 
who returned for a subsequent annual visit and had data on BP (n 165), mean systolic BP did 
not differ statistically between enrollment and the subsequent annual visit (119 mmHg at 
both visits, p = 0.983), but the overall mean diastolic BP decreased 2 mmHg at the 
subsequent annual visit (76 to 74 mmHg, p = 0.007).
Five women identified with diabetes at screening were rescreened. The overall mean 
hemoglobin A1c was slightly higher at rescreening but not statistically different compared 
with the screening visit (7.9% versus 7.5%, respectively, p = 0.640, Table 2). In sensitivity 
analyses that included all women who were rescreened and had data on A1c (n = 160), the 
overall mean A1c did not differ statistically between the screening and rescreening visits 
(6% at both visits, p = 0.820).
Among 148 women who reported smoking at enrollment, 129 (87.2%) received cessation 
counseling and 8 (5.4%) accepted tobacco quitline referrals. Of those referred, one accepted 
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services and received multiple counseling sessions plus the nicotine patch, another woman 
declined services as she was already receiving quitline services, and six were unreachable. 
Of 148 smokers, 53 (35.8%) returned for their subsequent annual visit and 11 (20.9%) 
reported nonsmoking at that time (p < 0.001, Table 3). In a sensitivity analysis that included 
all women who were rescreened and had data on smoking (n = 165), prevalence of smoking 
was lower at rescreening (46/165, 27.9%) but not statistically different from smoking 
prevalence at screening (53/165, 32.1%, p = 0.071).
Among 188 women identified as obese at enrollment, 22 (11.7%) scheduled nutrition 
appointments, but only one attended. Six obese participants who returned for a subsequent 
annual visit lost weight and were no longer obese (Table 3). However, the mean weight 
significantly increased between enrollment (221 lbs.) and the subsequent annual visit (225 
lbs.) among obese women who were rescreened (n = 70, p = 0.047). In a sensitivity analysis 
that included all women who returned for a subsequent annual visit and had data on weight 
(n = 165), the overall mean weight also increased from 175 to 181 lbs. between visits (p < 
0.001).
Discussion
Of women who were screened, approximately one-third were rescreened at their next annual 
family planning visit; more than half did not return to the clinic, declined participation, or 
were missed; and an additional 10% became pregnant. Most women who were newly 
diagnosed with hypertension or diabetes were offered referrals. However, only 2 of 11 
women with newly diagnosed hypertension or diabetes completed referrals, even though the 
majority of referrals were formally facilitated by the health department.
Reported referral completion rates among similar populations of women who receive formal 
referrals for abnormal Pap tests are substantially higher. A study of Medicaid-enrolled 
family planning providers in Arkansas and Alabama found 62.4% of their patients reported 
receiving follow up care for an abnormal Pap test.7 Some women were treated on-site by 
their family planning providers, while others received external referrals. Among women 
who were not treated on-site but were referred for follow up, 40.5% completed the 
referrals.7
The difference in referral completion rates between our study and those reported by the 
aforementioned study of low-income family planning women7 is notable. An important 
difference between the two studies is the condition of interest. The earlier study examined 
follow up for cervical cancer screening. There is a culture that supports cancer screening and 
taking action for abnormal results from cancer screening tests, in part due to the perceived 
suffering generated by cancer.10 The same culture may not exist for other diseases and 
conditions, such as CVD risk factors, which may not be perceived by patients as debilitating 
or life threatening. In the absence of such a culture, it may be difficult to engage women in 
taking action for asymptomatic problems—such as hypertension. Moreover, follow up rates 
in the Pap test study7 were higher among women who were treated by the same family 
planning provider that did the screening, compared with those who were referred to other 
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providers. It is possible that follow up for hypertension and diabetes would have been more 
successful if treated on-site rather than by referral.
Since Title X clinics are expected to treat on-site or make referrals to meet their low-income 
clientele’s additional health care needs,11 the very low referral completion rates reported in 
this study are concerning. Screening for hypertension and smoking are quality standards of 
care for safe and effective use of some forms of contraception, particularly hormonal 
contraceptive methods. Screening for obesity and diabetes, as clinically indicated, is 
considered part of preconception care,3 which is a component of family planning services.11 
Therefore, understanding the outcomes of referrals made in these settings has important 
programmatic implications for Title X and other health care systems concerned with 
ensuring access to quality, comprehensive care.
Finding primary care providers who will accept referrals for uninsured and indigent patients 
can be challenging.12 This barrier is particularly difficult for Title X family planning clinics, 
which often are located in resource-limited areas. Unlike many rural communities, Pitt 
County does not have this barrier, as there are multiple medical resources that could provide 
referral care for indigent patients with CVD risk factors, including a state-supported 
academic medical center and a federally qualified CHC. In our study, most women were 
referred to the CHC, which uses a standard sliding fee scale for low-income patients.
Referrals to telephone quitlines for smoking cessation pose no financial barriers to women, 
as quitlines are free and offer assistance that may not be available to uninsured smokers 
elsewhere.13 Unfortunately, in this study, most women who accepted telephone quitline 
referrals were later unreachable. On-the-spot interventions (e.g., prescriptions for 
pharmacotherapy) and same-day referrals may be more successful. Brief clinical 
interventions—such as five A’s cessation counseling— are effective9 and clinicians might 
consider incorporating these during family planning clinic visits, as was done at the health 
department. Smoking cessation might also increase if one-on-one counseling sessions with 
tobacco-cessation specialists were available, as was demonstrated by a Well-Integrated 
Screening and Evaluation for Women across the Nation (WISEWOMAN) program in 
Alaska among women aged 40–64 years.14 However, participation in counseling sessions 
and impact of cessation rates may differ between reproductive age and older women. 
Moreover, the additional cost and time required to incorporate these services into routine 
medical visits needs to be examined.
While health care access does not always translate into utilization,15 it is unknown why the 
majority of women with CVD risk factors in this study did not receive needed follow-up 
care. Implementation of electronic medical records may alert clinicians to noncompletion of 
referrals and trigger follow up on failed referrals when patients return to the clinic. Tangible 
solutions to patient-level reasons for noncompletion of referrals are less clear. For example, 
some research among similar populations suggests fatalism and having previous negative 
experiences with health care providers as reasons for nonuse of breast cancer screening 
when such care is available and accessible.16 Additionally, a recent systematic review 
reported that prioritizing clinic visits over the needs of family members and work was 
commonly reported by patients as a barrier to hypertension treatment and follow up.17 
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Finally, low referral completions in our study may be explained by financial and 
transportation barriers and delays in referral appointment dates.
Since the health department is the usual source of care for the majority of women in this 
sample,2 it is also unclear why nearly half did not return for their subsequent annual visits. 
Low-income women of reproductive age, particularly those with young children, can have 
limited free time and competing priorities. Therefore, timely preventive health care visits 
may not rise to the top of the daily demands. However, interruption of contraceptive services 
is likely to result in unplanned pregnancies. Additionally, the discontinuity of care 
represented by the low rescreening rates presents challenges for providing preconception 
care and preventing unintended pregnancies—both of which are essential components of 
quality family planning services and Title X.11 It is possible that rescreening rates would 
have been higher among this population if all women participating had the opportunity to be 
rescreened up to 18 months after the initial screening. Our rescreening period captured all 
women who were screened and rescreened 12–13 months later. However, women who were 
screened earlier during the interval of May 2011–February 2012 had longer to get 
rescreened than those who were screened later.
The limitations of the screening study were previously elucidated and included possible 
overestimation of hypertension prevalence, potential selection and recall bias, and the 
generalizability of results.2 Although the rescreened sample constitutes only 36% of the 
initial sample of women who were screened at enrollment, women who were rescreened did 
not differ on baseline characteristics from those who were not rescreened. However, it is 
likely that we did not measure all characteristics that affect health care–seeking behavior. 
Finally, evaluating improvements among women who screened positive for CVD risk 
factors was limited by the small sample. Nevertheless, few published studies have examined 
outcomes of screening for CVD risk factors in women of reproductive age; therefore, this 
study contributes to that small literature.
Conclusions
Women attending Title X clinics are routinely screened for several CVD risk factors, but 
previous studies have not examined the outcomes of that screening. This study found that 
the majority of women with newly identified CVD risk factors received indicated referrals, 
but few women completed those referrals. Treating CVD risk factors can impact the long-
term health of women and improve their pregnancy outcomes. Thus, research is needed to 
(1) improve understanding about the barriers and facilitators to receiving referral care for 
management of CVD risk factors among low-income women of reproductive age, (2) 
explore the feasibility of managing CVD risk factors on-site in Title X settings, and (3) 
identify best practices in managing these risk factors for women who screen positive in these 
settings.
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Flow diagram of referral outcomes for women identified with hypertension or diabetes at 
screening visit among Integrated Screening and Health Assessment, Prevention and 
Evaluation screening study participants, North Carolina, 2011–2012.
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Table 3
Status of Smoking and Obesity Among InShape Participants Who Smoked or Were Obese at Screening and 
Were Rescreened One Year Later (North Carolina, 2011–2013)
Status of CVD risk factors Screening visit n (%) Rescreening visit n (%) Chi square p value
Cigarette smokersa (n = 53) 0.0005
 Nonsmoker 0 (0) 11 (21)
 Smoker 53 (100) 42 (79)
Weight (pounds), mean (SE) (n = 70) 221 (5.3) 225 (5.3) 0.0465
BMI (kg/m2),b (n = 70) < 0.0001
 Underweight/normal (< 24.9) 0 (0) (0)
 Overweight (25–29.9) 0 (0) 6 (9)
 Obese (30.0–39.9) 50 (71) 42 (60)
 Extremely obese (≥ 40.0) 20 (29) 22 (31)
Due to rounding, percentages may not add to 100%.
a
Defined by self-reported smoking.
b
Calculated from clinically measured height and weight.
CVD, cardiovascular disease.
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